Cargando…
Crystal Ball Health Policies: A Case Against Preventive Testing For Alzheimer’s Disease
After the recent approval of a new drug for the treatment of Alzheimer’s disease, the first in almost twenty years, it is useful to consider what are the real possibilities to make a preclinical diagnosis of dementia and to treat its symptoms. The scientific community widely agrees that the drugs av...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886442/ https://www.ncbi.nlm.nih.gov/pubmed/35242026 http://dx.doi.org/10.3389/fnagi.2022.842629 |